Oncology Department, FFH hosted an insightful clinical symposium focusing on recent advancements in HER2-positive breast & EGFR-positive lung cancers. The educational event brought together healthcare professionals across the North region to discuss targeted treatments, molecular testing & personalized patient care. This is a testament of our ongoing commitment to integrating precision oncology into our clinical practice.
